Molecular profiling of angiogenesis markers

American Journal of Pathology

Volumn 161, Issue 1, 2002, Pages 35-41

  Shih, Shu Ching ^a   Robinson, Gregory S ^a,d   Perruzzi, Carole A ^c   Calvo, Alfonso ^b   Desai, Kartiki ^b   Green, Jeffery E ^b   Ali, Iqbal U ^b   Smith, Lois E H ^a   Senger, Donald R ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; CADHERIN; CD31 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; MESSENGER RNA; MOLECULAR MARKER; PROTEIN TYROSINE KINASE; TIE 1 RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; HUMAN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SKIN; TRANSGENIC MOUSE;

EID: 0036310275     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64154-5     Document Type: Article

References (34)

1. What is the evidence that tumors are angiogenesis dependent?
2. Blood vessel formation: What is its molecular basis?
3. The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis
4. Real time quantitative PCR
5. Quantitative PCR
6. Quantitative RT-PCR pitfalls and potential
7. Detection and quantification of protein phosphatase inhibitor-1 gene expression in total rat liver and isolated hepatocytes
8. Molecular quantification and mapping of lymph-node micrometastases in cervical cancer
9. Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system
10. Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin)
11. Thrombospondin-1, PECAM-1, and regulation of angiogenesis
12. The biology of PECAM-1
13. Regulation of angiogenesis via vascular endothelial growth factor receptors
14. Angiopoietin growth factors and Tie receptor tyrosine kinases in renal vascular development
15. Endothelial receptor tyrosine kinases involved in angiogenesis
16. Tek/Tie2 signaling: New and old partners
17. Functions of Tie1 and Tie2 receptor tyrosine kinases in vascular development
18. Tie receptors: New modulators of angiogenic and lymphangiogenic responses
19. Role of vascular endothelial growth factor in regulation of physiological angiogenesis
20. Vascular permeability factor (VPF, VEGF) in tumor biology
21. Vascular-specific growth factors and blood vessel formation
22. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
23. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
24. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors
25. Peptide growth factors and prostate cancer: New models, new opportunities
26. Autochthonous mouse models for prostate cancer: Past, present, and future
27. Metastatic prostate cancer in a transgenic mouse
28. Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L
29. Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development
30. Structural and evolutionary relationships among the immunophilins: Two ubiquitous families of peptidyl-prolyl cis-trans isomerases
31. Inhibition of angiogenesis
32. Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR), and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas
33. Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression
34. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma